Yahoo Web Search

Search results

    • A Surprise Big Name Enters The Weight-Loss Melee

      A Surprise Big Name Enters The Weight-Loss Melee

      Investor's Business Daily· 6 days ago

      Evercore ISI analyst Umer Raffat said Gilead Sciences (GILD) hasn't been hyping the potential rival to Eli Lilly (LLY) and Structure Therapeutics (GPCR)....

    • Why Wall Street Is Chasing Ozempic Wannabes

      Why Wall Street Is Chasing Ozempic Wannabes

      The Wall Street Journal· 7 hours ago

      HEARD ON THE STREET Gilead Sciences a biotech company focused on treatments for cancer and HIV, isn’t pitching itself as an obesity-drug developer. But...